The stock gave returns of -4.9 per cent in just 1 year, and mutlibagger returns of 6,681 per cent in 5 years and over 14,201 per cent in a decade.

Between FY22 and FY24, the company delivered an impressive Compound Annual Growth Rate (CAGR) of 117 per cent in revenue and 262 per cent in net profit.

Since listing in December 2024, the stock has given 97 per cent returns.

The stock has delivered a return of 73.65 per cent over the past year and 7.1 per cent in the past week.

This article is authored by Ms Shivani Wagh, Joint Managing Director, Supriya Lifescience Ltd

Top 3 price-volume breakout stocks

The stock gave multibagger returns of 333 per cent in 3 years and 875 per cent in 5 years.

The stock price gave multibagger returns of 339 per cent in 3 years and a whopping 17,500 per cent in 5 years.

The stock is down by 44 per cent in last 12 months.

The President of India’s portfolio owns 63.17 per cent and Life Insurance Corporation of India’s portfolio owns 6.72 per cent as of March 2025

In the last one-month, the stock has gained over 36 per cent.